Immediate Impact
4 from Science/Nature 71 standout
Citing Papers
Targeting KRAS in cancer
2024 Standout
TTD: Therapeutic Target Database describing target druggability information
2023 Standout
Works of Anne Keating being referenced
A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma
2016
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anne Keating | 407 | 190 | 632 | 26 | 890 | |
| Carmela De Marco | 330 | 192 | 674 | 32 | 973 | |
| Robert Cornelison | 294 | 113 | 755 | 28 | 1.1k | |
| Amit J. Sabnis | 244 | 124 | 547 | 29 | 922 | |
| Raymond Wadlow | 477 | 177 | 475 | 35 | 927 | |
| Alexandra Florin | 384 | 185 | 670 | 27 | 1.1k | |
| Katharina König | 353 | 228 | 555 | 20 | 1.0k | |
| John I. Song | 489 | 205 | 486 | 33 | 1.1k | |
| Kai Doberstein | 293 | 114 | 515 | 26 | 1.1k | |
| Simon A. Williams | 337 | 178 | 520 | 24 | 958 | |
| Tsuyoshi Takahashi | 411 | 138 | 419 | 33 | 1.0k |
All Works
Loading papers...